Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
33.71 36.53 45.15 40.63

+8 more quarters

P/S ratio
5.35 5.42 6.64 5.81
P/FCF ratio
24.48 25.24 30.82 28.02
P/Operating CF
87.58 101.53 77.07 84.78
P/B ratio
2.55 2.53 3.11 2.76
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
6.18 5.90 7.20 6.44
EV/EBITDA
20.14 20.17 24.79 22.21
EV/Operating CF
23.38 22.69 27.58 24.72
EV/FCF
28.26 27.47 33.43 31.07
Quick Ratio
1.03 1.28 1.25 0.84
Current Ratio
1.65 1.87 1.87 1.52
Net Debt/EBITDA
11.35 6.02 6.49 8.62
Debt/Assets
27.23% 21.02% 22.06% 21.07%
Debt/Equity
0.48 0.33 0.35 0.33
Asset Turnover
0.29 0.30 0.31 0.30
Operating CF/Net income
1.76 1.28 1.77 1.83
Capex/Depreciation
(0.38) (0.38) (0.56) (0.47)
Interest Coverage
10.53 21.33 27.31 17.22
Research and Development Expense of Revenue
6.58% 6.50% 6.41% 6.24%
Selling, General and Administrative Expense of Revenue
33.07% 31.26% 29.63% 32.89%
Intangible Assets out of Total Assets
0.74 0.72 0.73 0.76
Share Based Compensation of Revenue
1.48% 0.97% 0.92% 1.37%
Graham Net Nets
(0.20) (0.12) (0.11) (0.14)
Graham Number
97.36 93.47 91.70 88.83
Earnings Yield
2.97% 2.74% 2.21% 2.46%
Free Cash Flow Yield
4.09% 3.96% 3.24% 3.57%
Revenue per Share
8.88 8.41 9.59 8.52
Operating CF per Share
2.18 1.87 2.97 2.34
Capex per Share
(0.38) (0.33) (0.49) (0.41)
Free Cash Flow per Share
1.79 1.53 2.48 1.93
Cash per Share
6.16 8.05 6.48 2.15
Shareholders Equity per Share
74.57 74.81 73.72 71.87
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
74.57 74.81 73.72 71.87
Free Cash Flow
1,265.00 1,085.00 1,769.00 1,370.00
Working Capital
5,276.00 6,475.00 5,949.00 3,282.00
Capital Expenditures
(269.00) (237.00) (348.00) (292.00)
Net Current Asset Value
(26,394.00) (16,652.00) (18,167.00) (19,211.00)
EV/EBIT
30.26 30.69 37.73 33.86
Capex to Sales
0.04 0.04 0.05 0.05
Price to Operating Income
26.20 28.20 34.79 30.54
Other line items
Average Receivables
3,764.50 3,662.50 3,725.00 3,631.00
Average Payables
1,773.50 1,756.00 1,798.50 1,647.00
Average Inventory
2,974.50 2,570.00 2,409.50 2,676.00
Average Assets
86,993.50 81,330.00 80,503.00 80,256.00
Average Common Equity
52,467.00 51,907.00 51,045.50 51,192.50

Fold the line items

Columns are period end dates